Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pande

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Drug Discovery Today|March 7, 2024
Treating liver cancer through arginine depletionYenisetti Rajendra Prasad, J Anakha, Abhay H Pande
Vascular Pharmacology|December 21, 2024
Endostatin in disease modulation: From cancer to beyondJ Anakha, Yenisetti Rajendra Prasad, Abhay H Pande
Biochimica Et Biophysica Acta. General Subjects|November 1, 2023
Towards development of biobetter: L-asparaginase a case studyRajan K Tripathy, J Anakha, Abhay H Pande
Biophysical Journal|March 22, 2005
Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenaseAbhay H Pande, Shan Qin, Suren A Tatulian
Experimental Neurology|March 22, 2022
Therapeutic potential of ApoE-mimetic peptides in CNS disorders: Current perspectiveSakeel Ahmed, Abhay H Pande, Shyam Sunder Sharma
Experientia|November 15, 1976
Structure and stereochemistry of Coccuvine (Cocculus laurifolius DC)A N Singh, H Pande, D S Bhakuni
Future Oncology (London, England)|May 19, 2025
Amino acid deprivation vs. mainstream cancer therapeutics: exploring the potential and limitationsAbhay H Pande, Yenisetti Rajendra Prasad, J Anakha
Scandinavian Journal of Infectious Diseases|January 1, 1972
Unusually high titres of antibodies to rubella virus in a patient with chronic hepatitisO Closs, G Haukenes, P Bjark, et al.
Biochimica Et Biophysica Acta|January 12, 2010
Oxidatively modified fatty acyl chain determines physicochemical properties of aggregates of oxidized phospholipidsAbhay H Pande, Subhabrata Kar, Rajan K Tripathy
Lloydia|July 1, 1977
Cocculitine, a new abnormal Erythrina alkaloid from Cocculus laurifoliusA N Singh, H Pande, D S Bhakuni
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Drug Discovery Today|March 7, 2024
Treating liver cancer through arginine depletionYenisetti Rajendra Prasad, J Anakha, Abhay H Pande
Vascular Pharmacology|December 21, 2024
Endostatin in disease modulation: From cancer to beyondJ Anakha, Yenisetti Rajendra Prasad, Abhay H Pande
Biochimica Et Biophysica Acta. General Subjects|November 1, 2023
Towards development of biobetter: L-asparaginase a case studyRajan K Tripathy, J Anakha, Abhay H Pande
Biophysical Journal|March 22, 2005
Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenaseAbhay H Pande, Shan Qin, Suren A Tatulian
Experimental Neurology|March 22, 2022
Therapeutic potential of ApoE-mimetic peptides in CNS disorders: Current perspectiveSakeel Ahmed, Abhay H Pande, Shyam Sunder Sharma
Experientia|November 15, 1976
Structure and stereochemistry of Coccuvine (Cocculus laurifolius DC)A N Singh, H Pande, D S Bhakuni
Future Oncology (London, England)|May 19, 2025
Amino acid deprivation vs. mainstream cancer therapeutics: exploring the potential and limitationsAbhay H Pande, Yenisetti Rajendra Prasad, J Anakha
Scandinavian Journal of Infectious Diseases|January 1, 1972
Unusually high titres of antibodies to rubella virus in a patient with chronic hepatitisO Closs, G Haukenes, P Bjark, et al.
Biochimica Et Biophysica Acta|January 12, 2010
Oxidatively modified fatty acyl chain determines physicochemical properties of aggregates of oxidized phospholipidsAbhay H Pande, Subhabrata Kar, Rajan K Tripathy
Lloydia|July 1, 1977
Cocculitine, a new abnormal Erythrina alkaloid from Cocculus laurifoliusA N Singh, H Pande, D S Bhakuni
Pageof 15